Zurcher Kantonalbank (Zurich Cantonalbank) Dynavax Technologies Corp Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 25,880 shares of DVAX stock, worth $302,537. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,880

Previous 25,880 -0.0%

Holding current value

$302,537

Previous $288,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$10.05 - $11.61 $926,177 - $1.07 Million	-92,157 Reduced 78.07%	25,880 $288,000
Q2 2024 Jul 29, 2024	BUY	$10.73 - $12.58 $12,575 - $14,743	1,172 Added 1.0%	118,037 $1.33 Million
Q1 2024 Apr 25, 2024	SELL	$11.7 - $14.98 $62,501 - $80,023	-5,342 Reduced 4.37%	116,865 $1.45 Million
Q4 2023 Jan 30, 2024	SELL	$13.09 - $14.98 $645,664 - $738,888	-49,325 Reduced 28.76%	122,207 $1.71 Million
Q3 2023 Oct 25, 2023	SELL	$12.64 - $14.99 $2.68 Million - $3.18 Million	-211,962 Reduced 55.27%	171,532 $2.53 Million
Q2 2023 Aug 07, 2023	SELL	$9.85 - $13.17 $22,024 - $29,448	-2,236 Reduced 0.58%	383,494 $4.95 Million
Q1 2023 May 08, 2023	BUY	$9.44 - $11.88 $36,466 - $45,892	3,863 Added 1.01%	385,730 $3.78 Million
Q4 2022 Feb 01, 2023	SELL	$10.27 - $13.29 $1,879 - $2,432	-183 Reduced 0.05%	381,867 $4.06 Million
Q3 2022 Nov 09, 2022	BUY	$9.93 - $17.44 $120,123 - $210,971	12,097 Added 3.27%	382,050 $3.99 Million
Q1 2022 Apr 21, 2022	BUY	$9.75 - $14.44 $13,776 - $20,403	1,413 Added 0.38%	369,953 $4.01 Million
Q4 2021 Feb 01, 2022	BUY	$13.17 - $20.94 $127,880 - $203,327	9,710 Added 2.71%	368,540 $5.19 Million
Q3 2021 Nov 15, 2021	SELL	$9.16 - $19.83 $963,174 - $2.09 Million	-105,150 Reduced 22.66%	358,830 $6.89 Million
Q2 2021 Jul 30, 2021	SELL	$7.25 - $10.99 $1,580 - $2,395	-218 Reduced 0.05%	463,980 $4.57 Million
Q1 2021 May 03, 2021	BUY	$4.57 - $11.18 $942,740 - $2.31 Million	206,289 Added 79.99%	464,198 $4.56 Million
Q4 2020 Jan 28, 2021	BUY	$3.73 - $5.6 $305,986 - $459,390	82,034 Added 46.64%	257,909 $1.15 Million
Q3 2020 Nov 06, 2020	BUY	$4.32 - $11.7 $700,133 - $1.9 Million	162,068 Added 1173.81%	175,875 $760,000
Q2 2020 Jul 28, 2020	BUY	$2.94 - $9.1 $16,137 - $49,949	5,489 Added 65.99%	13,807 $122,000
Q1 2020 May 06, 2020	BUY	$2.27 - $6.2 $12,055 - $32,928	5,311 Added 176.62%	8,318 $29,000
Q2 2019 Jul 30, 2019	SELL	$3.65 - $7.89 $8,322 - $17,989	-2,280 Reduced 43.12%	3,007 $12,000
Q3 2018 Nov 09, 2018	BUY	$11.85 - $16.0 $7,465 - $10,080	630 Added 13.53%	5,287 $66,000
Q1 2018 May 03, 2018	SELL	$14.65 - $19.9 $52,740 - $71,640	-3,600 Reduced 43.6%	4,657 $92,000
Q4 2017 Jan 31, 2018	BUY	$17.3 - $24.08 $19,670 - $27,378	1,137 Added 15.97%	8,257 $154,000
Q3 2017 Nov 08, 2017	BUY	$15.2 - $21.5 $108,224 - $153,080	7,120	7,120 $153,000

Others Institutions Holding DVAX

# of Institutions

273

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.48B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Dynavax Technologies Corp Transaction History